Techcyte bundles digital pathology with Epredia scanners through Fisher Healthcare
Techcyte has launched a per-slide digital pathology bundle through Fisher Healthcare that pairs its Fusion AP platform with Epredia slide scanners. The offering is meant to help labs digitize workflows without a large upfront capital purchase.
Why it matters: - The bundle shifts digital pathology from a capital purchase to an operating expense. - Labs can start scanning at volume and pay based on usage. - The model is aimed at laboratories with a wide range of annual slide volumes.
What happened: - Techcyte announced a new bundled digital pathology offering available through Fisher Healthcare. - The package combines the Techcyte Fusion® AP digital pathology platform with high-throughput slide scanners from Epredia. - The launch was announced Oct. 15, 2026. - Attendees at Pathology Visions 2026 in San Diego can learn more about the offering Oct. 16–18 at Techcyte booth 410 and Epredia booth 301.
The details: - The bundle includes scanners, five years of service and maintenance, Fusion AP software and 30 days of active cloud storage. - Archival storage is available after the initial 30-day period. - The per-slide fee is designed to cover the full package in a single pricing structure. - Labs can choose between the 3DHISTECH Pannoramic P1000 Digital Pathology Solution and the 3DHISTECH Pannoramic 480 for slide scanning. - Techcyte Fusion® AP is for Research Use Only in the United States and is not for use in diagnostic procedures.
Between the lines: - The bundle is positioned to remove one of the biggest barriers to digital pathology adoption: upfront hardware cost. - Techcyte and Epredia already collaborate in microbiology and cytology, which suggests this launch extends an existing partnership. - ARUP Laboratories uses Techcyte's AI-assisted parasitology trichrome screening on Epredia-supplied scanners. - CorePlus in Puerto Rico evaluated Techcyte's cervical cytology software on Epredia-supplied scanners in a study published in Cancer Cytopathology.
What's next: - Techcyte and Epredia will use Pathology Visions 2026 to showcase the offering and related products. - The per-slide model could broaden access for labs that want to digitize workflows without a large initial outlay. - More adoption will likely hinge on how labs weigh scanning volume, service coverage and storage needs against existing workflows.
The bottom line: - Techcyte is betting that a pay-as-you-scan bundle will make digital pathology easier for more labs to adopt.
Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.
Sign up for:
Today in Healthcare
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.